CORT Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 20.70%

Insider Buying (Last 12 Months): $3,314,000.00

Insider Selling (Last 12 Months): $92,729,238.49

Corcept Therapeutics Insider Trading History Chart

Corcept Therapeutics Share Price & Price History

^$80.46

▼ -0.66 (-0.81%)

As of 11/2/2026 04:00 PM ET

Days: 30 | 90 | 365

Corcept Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/15/2026	James N. Wilson	Director	Sell	10,000	$114.81	$1,148,100.00	1,054,543
10/2/2026	Joseph Douglas Lyon	Insider	Sell	9,190	$116.13	$1,067,234.70	5,683
10/2/2026	Roberto Wandenkolk Vieira	Insider	Sell	8,333	$116.10	$967,461.30	3,946
10/2/2026	Sean Maduck	Insider	Sell	24,587	$116.28	$2,858,976.36	9,938
10/1/2026	Joseph Douglas Lyon	Insider	Sell	810	$115.40	$93,474.00	5,683
10/1/2026	Sean Maduck	Insider	Sell	413	$115.54	$47,718.02	9,938
9/16/2026	Roberto Wandenkolk Vieira	Insider	Sell	296	$100.82	$29,842.72	3,946
9/15/2026	James N. Wilson	Director	Sell	10,000	$110.69	$1,106,900.00	1,064,543
9/14/2026	Joseph Douglas Lyon	Insider	Sell	10,000	$113.49	$1,134,900.00	5,683
9/2/2026	Roberto Wandenkolk Vieira	Insider	Sell	58,333	$110.76	$6,460,963.08	4,242
9/1/2026	Sean Maduck	Insider	Sell	25,000	$114.43	$2,860,750.00	9,755
8/26/2026	Kimberly Park	Director	Sell	26,685	$122.55	$3,270,246.75	30,000
8/25/2026	Sean Maduck	Insider	Sell	30,955	$125.58	$3,887,328.90	9,755
8/18/2026	David L. Mahoney	Director	Sell	103,606	$118.25	$12,251,409.50	1,133,539
8/14/2026	James N. Wilson	Director	Sell	10,000	$111.43	$1,114,300.00	1,074,543
8/14/2026	Sean Maduck	Insider	Sell	3,664	$114.49	$419,491.36	9,755
8/10/2026	Sean Maduck	Insider	Sell	1,031	$114.52	$118,070.12	9,755
8/10/2026	William Guyer	Insider	Sell	16,300	$113.43	$1,848,909.00	3,985
8/4/2026	William Guyer	Insider	Sell	3,700	$113.12	$418,544.00	3,985
8/3/2026	Joseph Douglas Lyon	Insider	Sell	1,540	$114.16	$175,806.40	5,495
8/3/2026	Sean Maduck	Insider	Sell	20,305	$114.70	$2,328,983.50	9,755
7/30/2026	Atabak Mokari	CFO	Sell	80,000	$114.71	$9,176,800.00	16,130
7/7/2026	William Guyer	Insider	Sell	20,000	$93.13	$1,862,600.00	3,985
7/1/2026	Sean Maduck	Insider	Sell	25,000	$88.35	$2,208,750.00	9,755
6/17/2026	David L. Mahoney	Director	Sell	20,000	$84.53	$1,690,600.00	26,147
6/16/2026	James N. Wilson	Director	Sell	10,000	$83.20	$832,000.00	1,094,543
6/15/2026	Atabak Mokari	CFO	Sell	40,000	$81.15	$3,246,000.00	16,130
6/2/2026	William Guyer	Insider	Sell	20,000	$70.60	$1,412,000.00	3,985
6/1/2026	Atabak Mokari	CFO	Sell	40,000	$70.00	$2,800,000.00	15,257
6/1/2026	Sean Maduck	Insider	Sell	25,000	$70.21	$1,755,250.00	8,977
5/27/2026	Joseph Douglas Lyon	Insider	Sell	5,000	$65.00	$325,000.00	6,230
5/27/2026	Sean Maduck	Insider	Sell	75,000	$65.59	$4,919,250.00	8,977
5/5/2026	William Guyer	Insider	Sell	20,000	$51.83	$1,036,600.00	2,231
4/7/2026	William Guyer	Insider	Sell	20,000	$40.97	$819,400.00	2,231
3/25/2026	Joseph K. Belanoff	CEO	Sell	26,198	$50.07	$1,311,733.86	2,918,326
3/20/2026	William Guyer	Insider	Sell	11,767	$36.01	$423,729.67	2,231
3/17/2026	G Leonard Baker Jr	Director	Buy	100,000	$33.14	$3,314,000.00	1,146,631
3/4/2026	William Guyer	Insider	Sell	8,233	$35.99	$296,305.67	2,231
2/3/2026	William Guyer	Insider	Sell	20,000	$40.87	$817,400.00	1,235
1/6/2026	William Guyer	Insider	Sell	20,000	$35.18	$703,600.00	1,235
12/2/2025	William Guyer	Insider	Sell	20,000	$80.08	$1,601,600.00	1,235
12/1/2025	Joseph Douglas Lyon	Insider	Sell	5,000	$79.53	$397,650.00	10,277
12/1/2025	Joseph K. Belanoff	CEO	Sell	40,000	$79.77	$3,190,800.00	2,701,370
12/1/2025	Sean Maduck	Insider	Sell	20,000	$79.52	$1,590,400.00	7,904
11/25/2025	William Guyer	Insider	Sell	4,500	$80.90	$364,050.00	787
11/5/2025	Joseph K. Belanoff	CEO	Sell	28,782	$74.77	$2,152,030.14	2,741,370
11/5/2025	William Guyer	Insider	Sell	20,000	$75.36	$1,507,200.00	5,287
11/3/2025	Joseph Douglas Lyon	Insider	Sell	5,000	$73.65	$368,250.00	10,277
11/3/2025	Joseph K. Belanoff	CEO	Sell	11,218	$74.08	$831,029.44	2,770,152
11/3/2025	Sean Maduck	Insider	Sell	20,000	$73.99	$1,479,800.00	7,904
10/10/2025	Daniel N. Swisher, Jr.	Director	Sell	2,200	$87.54	$192,588.00
10/7/2025	William Guyer	Insider	Sell	20,000	$89.94	$1,798,800.00	5,287
10/1/2025	Joseph Douglas Lyon	Insider	Sell	5,000	$84.75	$423,750.00	10,277
10/1/2025	Joseph K. Belanoff	CEO	Sell	40,000	$85.08	$3,403,200.00	2,781,370
10/1/2025	Sean Maduck	Insider	Sell	20,000	$85.06	$1,701,200.00	7,904
9/10/2025	Daniel N. Swisher, Jr.	Director	Sell	2,200	$72.45	$159,390.00
9/2/2025	Joseph Douglas Lyon	Insider	Sell	5,000	$70.25	$351,250.00	10,066
9/2/2025	Joseph K. Belanoff	CEO	Sell	40,000	$70.53	$2,821,200.00	2,821,370
9/2/2025	Sean Maduck	Insider	Sell	20,000	$70.49	$1,409,800.00	7,681
9/2/2025	William Guyer	Insider	Sell	20,000	$70.49	$1,409,800.00	5,487
8/11/2025	Daniel N. Swisher, Jr.	Director	Sell	2,200	$72.30	$159,060.00
8/8/2025	William Guyer	Insider	Sell	35,007	$71.77	$2,512,452.39	5,487
8/5/2025	William Guyer	Insider	Sell	14	$71.77	$1,004.78	5,487
8/1/2025	Joseph Douglas Lyon	Insider	Sell	5,823	$67.51	$393,110.73	10,066
8/1/2025	Joseph K. Belanoff	CEO	Sell	40,000	$68.53	$2,741,200.00	2,861,370
8/1/2025	Sean Maduck	Insider	Sell	35,007	$67.79	$2,373,124.53	7,681
7/18/2025	Joseph Douglas Lyon	Insider	Sell	200	$73.40	$14,680.00	10,066
7/18/2025	Sean Maduck	Insider	Sell	473	$73.44	$34,737.12	17,705
7/18/2025	William Guyer	Insider	Sell	500	$73.44	$36,720.00	5,487
7/17/2025	Joseph Douglas Lyon	Insider	Sell	3,877	$73.48	$284,881.96	10,066
7/17/2025	Joseph K. Belanoff	CEO	Sell	615	$73.69	$45,319.35	2,901,370
7/17/2025	Sean Maduck	Insider	Sell	4,315	$73.48	$317,066.20	17,705
7/17/2025	William Guyer	Insider	Sell	4,379	$73.48	$321,768.92	5,487
7/10/2025	Daniel N. Swisher, Jr.	Director	Sell	2,200	$71.08	$156,376.00
7/1/2025	Joseph Douglas Lyon	Insider	Sell	100	$73.50	$7,350.00	10,066
7/1/2025	Sean Maduck	Insider	Sell	205	$73.45	$15,057.25	17,705
7/1/2025	William Guyer	Insider	Sell	100	$73.50	$7,350.00	5,487
6/10/2025	Daniel N. Swisher, Jr.	Director	Sell	2,200	$70.61	$155,342.00
6/10/2025	William Guyer	Insider	Sell	20,000	$72.42	$1,448,400.00	5,487
6/2/2025	Joseph Douglas Lyon	Insider	Sell	5,000	$78.04	$390,200.00	9,009
6/2/2025	Joseph K. Belanoff	CEO	Sell	40,000	$82.86	$3,314,400.00	2,901,985
6/2/2025	Sean Maduck	Insider	Sell	20,000	$79.08	$1,581,600.00	17,705
5/16/2025	David L. Mahoney	Director	Sell	27,352	$74.23	$2,030,338.96
5/16/2025	William Guyer	Insider	Sell	32,262	$74.17	$2,392,872.54	5,487
5/12/2025	Daniel N. Swisher, Jr.	Director	Sell	2,200	$72.06	$158,532.00
5/6/2025	William Guyer	Insider	Sell	7,060	$74.31	$524,628.60	5,487
5/2/2025	Joseph K. Belanoff	CEO	Sell	40,000	$72.90	$2,916,000.00	2,941,985
5/2/2025	Sean Maduck	Insider	Sell	26,554	$72.23	$1,917,995.42	85,622
4/10/2025	Daniel N. Swisher, Jr.	Director	Sell	2,200	$70.22	$154,484.00
3/31/2025	Joseph K. Belanoff	CEO	Sell	35,102	$94.72	$3,324,861.44	2,982,335
3/31/2025	Sean Maduck	Insider	Sell	100,000	$100.54	$10,054,000.00	85,622
3/24/2025	Joseph Douglas Lyon	Insider	Sell	421	$60.58	$25,504.18	9,009
3/24/2025	Joseph K. Belanoff	CEO	Sell	1,974	$60.83	$120,078.42	3,017,437
3/3/2025	Joseph K. Belanoff	CEO	Sell	2,924	$60.91	$178,100.84	3,019,411
3/3/2025	Sean Maduck	Insider	Sell	18,303	$60.69	$1,110,809.07	85,622
2/10/2025	Daniel N. Swisher, Jr.	Director	Sell	2,200	$68.08	$149,776.00
1/10/2025	Daniel N. Swisher, Jr.	Director	Sell	2,200	$50.54	$111,188.00
1/2/2025	Sean Maduck	Insider	Sell	20,000	$50.39	$1,007,800.00	85,318
12/10/2024	Daniel N. Swisher, Jr.	Director	Sell	2,200	$59.46	$130,812.00
11/22/2024	Joseph Douglas Lyon	Insider	Sell	1,411	$56.72	$80,031.92	8,494
11/11/2024	Daniel N. Swisher, Jr.	Director	Sell	2,200	$59.88	$131,736.00
11/4/2024	William Guyer	Insider	Sell	3,394	$48.97	$166,204.18	5,796
11/1/2024	William Guyer	Insider	Sell	6,606	$48.97	$323,495.82	5,796
10/1/2024	Gary Charles Robb	Insider	Sell	11,000	$46.28	$509,080.00	22,772
9/3/2024	William Guyer	Insider	Sell	10,000	$35.30	$353,000.00	6,039
8/26/2024	Gary Charles Robb	Insider	Sell	3,101	$35.71	$110,736.71	23,190
8/1/2024	Daniel N. Swisher, Jr.	Director	Sell	150	$38.50	$5,775.00
8/1/2024	William Guyer	Insider	Sell	10,000	$38.67	$386,700.00	6,039
7/1/2024	Daniel N. Swisher, Jr.	Director	Sell	2,200	$32.81	$72,182.00
7/1/2024	Joseph Douglas Lyon	Insider	Sell	5,000	$32.49	$162,450.00	9,290
6/3/2024	Daniel N. Swisher, Jr.	Director	Sell	2,200	$30.21	$66,462.00
6/3/2024	Joseph Douglas Lyon	Insider	Sell	5,000	$30.18	$150,900.00	7,314
5/28/2024	Gary Charles Robb	Insider	Sell	11,000	$30.39	$334,290.00	20,203
5/13/2024	Sean Maduck	Insider	Sell	50,000	$28.00	$1,400,000.00	85,222
5/9/2024	Joseph Douglas Lyon	Insider	Sell	7,227	$26.00	$187,902.00	7,314
5/2/2024	Joseph Douglas Lyon	Insider	Sell	10,830	$26.00	$281,580.00	7,314
4/4/2024	Joseph Douglas Lyon	Insider	Sell	5,443	$26.00	$141,518.00	7,314
4/1/2024	Daniel N. Swisher, Jr.	Director	Sell	2,200	$25.30	$55,660.00
4/1/2024	Joseph Douglas Lyon	Insider	Sell	500	$26.01	$13,005.00	7,314
3/27/2024	Sean Maduck	Insider	Sell	25,953	$25.01	$649,084.53	85,222
3/18/2024	Sean Maduck	Insider	Sell	17,219	$25.00	$430,475.00	75,222
3/1/2024	Daniel N. Swisher, Jr.	Director	Sell	2,200	$23.59	$51,898.00
2/16/2024	Joseph Douglas Lyon	CAO	Sell	1,000	$26.00	$26,000.00	6,774
2/16/2024	Sean Maduck	Insider	Sell	27,068	$25.97	$702,955.96	74,455
2/1/2024	Daniel N. Swisher, Jr.	Director	Sell	2,200	$22.00	$48,400.00
1/2/2024	Daniel N. Swisher, Jr.	Director	Sell	2,200	$22.11	$48,642.00
12/22/2023	William Guyer	Insider	Sell	10,000	$32.00	$320,000.00	6,643
12/5/2023	Gary Charles Robb	Insider	Sell	1,381	$26.27	$36,278.87	27,602
12/4/2023	Joseph Douglas Lyon	CAO	Sell	2,432	$26.00	$63,232.00	5,854
12/1/2023	Daniel N. Swisher, Jr.	Director	Sell	2,200	$25.47	$56,034.00
12/1/2023	Joseph Douglas Lyon	CAO	Sell	2,568	$26.00	$66,768.00	5,854
12/1/2023	Sean Maduck	Insider	Sell	25,000	$25.56	$639,000.00	73,291

SEC Filings (Institutional Ownership Changes) for Corcept Therapeutics (NASDAQ:CORT)

93.61% of Corcept Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Corcept Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/3/2026	Allegiance Financial Group Advisory Services LLC	2,006	$0.23M	0.0%	N/A	0.002%
11/2/2026	Kestra Advisory Services LLC	8,170	$0.94M	0.0%	-25.1%	0.008%
11/2/2026	Commonwealth Equity Services LLC	7,387	$0.85M	0.0%	-23.4%	0.007%
10/31/2026	Boston Trust Walden Corp	235,673	$27.16M	0.2%	-46.5%	0.218%
10/31/2026	Chicago Partners Investment Group LLC	8,352	$0.72M	0.0%	+7.4%	0.008%
10/31/2026	Optimist Retirement Group LLC	3,858	$0.45M	0.2%	N/A	0.004%
10/30/2026	Provenance Wealth Advisors LLC	328	$38K	0.0%	N/A	0.000%
10/30/2026	Oregon Public Employees Retirement Fund	19,700	$2.27M	0.0%	-9.1%	0.018%
10/30/2026	Signature Equity Partners LLC	491	$57K	0.0%	-30.0%	0.000%
10/29/2026	Bridge City Capital LLC	65,530	$7.55M	1.6%	+21.8%	0.061%
10/29/2026	True Freedom Investing LLC	2,026	$0.23M	0.0%	N/A	0.002%
10/29/2026	Profund Advisors LLC	15,351	$1.77M	0.1%	+130.8%	0.014%
10/29/2026	ProShare Advisors LLC	3,615	$0.42M	0.0%	N/A	0.003%
10/29/2026	Vise Technologies Inc.	17,901	$2.06M	0.0%	+91.1%	0.017%
10/29/2026	Summit Global Investments	11,996	$1.38M	0.1%	N/A	0.011%
10/29/2026	State of Wyoming	1,582	$0.18M	0.0%	N/A	0.001%
10/28/2026	VIRGINIA RETIREMENT SYSTEMS ET Al	18,974	$2.19M	0.0%	-28.6%	0.018%
10/28/2026	Parcion Private Wealth LLC	3,645	$0.42M	0.0%	N/A	0.003%
10/28/2026	Choreo LLC	4,190	$0.48M	0.0%	+8.0%	0.004%
10/28/2026	Sage Rhino Capital LLC	2,343	$0.27M	0.0%	-23.1%	0.000%
10/28/2026	BOKF NA	12,163	$1.40M	0.0%	-49.2%	0.000%
10/28/2026	Motley Fool Asset Management LLC	3,501	$0.40M	0.0%	N/A	0.000%
10/28/2026	Pinnacle Wealth Planning Services Inc.	1,329	$0.15M	0.0%	-65.7%	0.000%
10/28/2026	Simplify Asset Management Inc.	20,568	$2.37M	0.0%	-22.2%	0.000%
10/27/2026	Black Diamond Financial LLC	21,198	$2.44M	0.2%	-12.4%	0.020%
10/26/2026	Oppenheimer & Co. Inc.	12,000	$1.38M	0.0%	-25.0%	0.011%
10/26/2026	Park Avenue Securities LLC	2,728	$0.31M	0.0%	-20.9%	0.003%
10/23/2026	Brucke Financial Inc.	2,080	$0.24M	0.1%	N/A	0.002%
10/23/2026	Signaturefd LLC	1,375	$0.16M	0.0%	+30.6%	0.001%
10/23/2026	Citizens Financial Group Inc. RI	6,259	$0.72M	0.0%	+56.6%	0.006%
10/23/2026	Wedbush Securities Inc.	2,316	$0.27M	0.0%	N/A	0.002%
10/23/2026	Sterling Capital Management LLC	216	$25K	0.0%	-65.5%	0.000%
10/22/2026	Yousif Capital Management LLC	20,836	$2.40M	0.0%	-10.1%	0.019%
10/22/2026	MBL Wealth LLC	2,977	$0.34M	0.0%	N/A	0.003%
10/22/2026	Root Financial Partners LLC	735	$85K	0.0%	N/A	0.001%
10/21/2026	Crossmark Global Holdings Inc.	2,042	$0.24M	0.0%	-19.8%	0.002%
10/21/2026	Englebert Financial Advisers LLC	7,348	$0.85M	0.8%	N/A	0.007%
10/21/2026	Quadrant Capital Group LLC	14,007	$1.65M	0.0%	+1.3%	0.013%
10/21/2026	Range Financial Group LLC	11,136	$1.28M	0.4%	N/A	0.010%
10/21/2026	Nisa Investment Advisors LLC	32,267	$3.72M	0.0%	+103.1%	0.030%
10/20/2026	Redwood Family Wealth LLC	2,000	$0.23M	0.2%	N/A	0.002%
10/19/2026	AA Financial Advisors LLC	2,192	$0.25M	0.0%	-56.2%	0.002%
10/17/2026	IFP Advisors Inc	1,345	$0.16M	0.0%	+48.0%	0.001%
10/17/2026	Encompass More Asset Management	5,986	$0.69M	0.1%	N/A	0.006%
10/15/2026	State of Alaska Department of Revenue	22,216	$2.56M	0.0%	-44.6%	0.021%
10/15/2026	Curated Wealth Partners LLC	3,191	$0.37M	0.0%	-90.9%	0.003%
10/14/2026	First Citizens Bank & Trust Co.	4,145	$0.48M	0.0%	-62.0%	0.004%
10/14/2026	Krilogy Financial LLC	7,404	$0.90M	0.0%	+21.2%	0.007%
10/13/2026	NorthCrest Asset Manangement LLC	5,342	$0.63M	0.0%	+38.6%	0.005%
10/13/2026	Perpetual Ltd	1,789	$0.21M	0.0%	N/A	0.002%
10/9/2026	Riversedge Advisors LLC	2,201	$0.25M	0.0%	N/A	0.002%
10/9/2026	Wedmont Private Capital	3,329	$0.40M	0.0%	+6.1%	0.003%
10/9/2026	Vilga Financial Planning LLC	13,046	$1.50M	0.9%	N/A	0.012%
10/9/2026	Breakwater Capital Group	2,732	$0.32M	0.0%	-3.5%	0.003%
10/9/2026	GAMMA Investing LLC	5,609	$0.65M	0.0%	+20.9%	0.005%
10/8/2026	Farther Finance Advisors LLC	3,639	$0.42M	0.0%	+261.4%	0.003%
9/23/2026	QRG Capital Management Inc.	9,042	$0.79M	0.0%	+25.4%	0.008%
9/23/2026	Envestnet Portfolio Solutions Inc.	10,617	$0.92M	0.0%	+1.8%	0.010%
9/9/2026	Sequoia Financial Advisors LLC	7,423	$0.65M	0.0%	N/A	0.007%
9/9/2026	Tidal Investments LLC	24,218	$2.11M	0.0%	+9.2%	0.022%
9/9/2026	Engineers Gate Manager LP	3,683	$0.32M	0.0%	-81.1%	0.003%
9/9/2026	Integrated Wealth Concepts LLC	6,423	$0.56M	0.0%	N/A	0.006%
9/9/2026	NewEdge Advisors LLC	11,041	$0.96M	0.0%	+17.9%	0.010%
9/9/2026	IFP Advisors Inc	909	$79K	0.0%	+568.4%	0.001%
9/8/2026	Allworth Financial LP	3,892	$0.34M	0.0%	+151.1%	0.004%
9/8/2026	Arizona State Retirement System	26,417	$2.30M	0.0%	+1.6%	0.024%
9/8/2026	Waverly Advisors LLC	3,516	$0.31M	0.0%	N/A	0.003%
9/8/2026	Nykredit A S	3,205	$0.28M	0.0%	N/A	0.003%
8/27/2026	Corient Private Wealth LP	12,198	$1.06M	0.0%	+108.4%	0.011%
8/26/2026	Amundi	9,751	$0.85M	0.0%	-14.4%	0.009%
8/26/2026	HighTower Advisors LLC	10,106	$0.88M	0.0%	-15.3%	0.009%
8/25/2026	VIRGINIA RETIREMENT SYSTEMS ET Al	26,574	$2.31M	0.0%	N/A	0.025%
8/23/2026	Wedmont Private Capital	3,139	$0.29M	0.0%	N/A	0.003%
8/23/2026	HB Wealth Management LLC	5,186	$0.45M	0.0%	N/A	0.005%
8/22/2026	denkapparat Operations GmbH	2,360	$0.21M	0.1%	N/A	0.002%
8/22/2026	Concurrent Investment Advisors LLC	13,380	$1.16M	0.0%	+65.2%	0.012%
8/21/2026	Nykredit A S	3,205	$0.28M	0.0%	N/A	0.003%
8/20/2026	Two Sigma Securities LLC	2,959	$0.26M	0.0%	N/A	0.003%
8/19/2026	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	202,743	$17.63M	0.0%	-6.8%	0.188%
8/19/2026	Van ECK Associates Corp	139,135	$12.10M	0.0%	-12.8%	0.129%
8/19/2026	Hsbc Holdings PLC	15,623	$1.38M	0.0%	+134.8%	0.014%
8/18/2026	Empowered Funds LLC	3,341	$0.29M	0.0%	N/A	0.003%
8/18/2026	Public Employees Retirement System of Ohio	27,596	$2.40M	0.0%	N/A	0.026%
8/17/2026	Capstone Investment Advisors LLC	2,726	$0.24M	0.0%	N/A	0.003%
8/17/2026	Transamerica Financial Advisors LLC	1,789	$0.16M	0.0%	N/A	0.002%
8/17/2026	Corient Private Wealth LP	6,541	$0.57M	0.0%	N/A	0.006%
8/17/2026	Bank of America Corp DE	328,565	$28.57M	0.0%	N/A	0.304%
8/15/2026	Freestone Grove Partners LP	995	$87K	0.0%	N/A	0.001%
8/15/2026	Odyssean LLC	14,271	$1.24M	0.2%	N/A	0.013%
8/15/2026	Man Group plc	71,491	$6.22M	0.0%	N/A	0.066%
8/15/2026	Jupiter Topco LLC	138,743	$12.06M	0.0%	N/A	0.128%
8/14/2026	Hsbc Holdings PLC	15,623	$1.38M	0.0%	N/A	0.014%
8/14/2026	Canada Pension Plan Investment Board	191,101	$16.62M	0.0%	N/A	0.177%
8/14/2026	Legal & General Group Plc	218,078	$18.96M	0.0%	N/A	0.202%
8/14/2026	The Manufacturers Life Insurance Company	30,914	$2.69M	0.0%	N/A	0.029%
8/14/2026	Algert Global LLC	38,040	$3.31M	0.0%	N/A	0.035%
8/13/2026	OMERS ADMINISTRATION Corp	30,700	$2.67M	0.0%	N/A	0.028%
8/13/2026	Sanctuary Advisors LLC	9,289	$0.81M	0.0%	N/A	0.009%
8/13/2026	Connor Clark & Lunn Investment Management Ltd.	81,569	$7.09M	0.0%	N/A	0.075%
8/12/2026	Evolve Private Wealth LLC	2,603	$0.23M	0.0%	N/A	0.002%

Data available starting January 2016

Corcept Therapeutics Incorporated engages in discovery and development of drugs for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States. It offers Korlym tablets medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous cushing's syndrome; and who have type 2 diabetes mellitus or glucose intolerance and have failed surgery or are not candidates for surgery. The company is also developing relacorilant, which is in phase III clinical trial for the treatment of cushing's syndrome; treatment for adrenal cancer and cortisol excess which is in phase 1b clinical trial; treatment for prostate cancer which is in phase II clinical trial; and nab-paclitaxel in combination with relacorilant, which is in phase III clinical trial to treat platinum-resistant ovarian tumors. In addition, it develops dazucorilant, which is in phase II clinical trial for the treatment of amyotrophic lateral sclerosis; miricorilant, which is in phase IIb trial for the treatment of nonalcoholic steatohepatitis; and treatment for antipsychotic induced weight gain that is in phase I trial. The company was incorporated in 1998 and is headquartered in Menlo Park, California.

Today's Range

Now: $80.46

$79.39

$82.23

50 Day Range

MA: $111.14

$80.46

$123.57

52 Week Range

Now: $80.46

$28.66

$126.38

Volume

1,591,469 shs

Average Volume

893,416 shs

Market Capitalization

$8.70 billion

P/E Ratio

191.58

Dividend Yield

N/A

Beta

0.4

Who are the company insiders with the largest holdings of Corcept Therapeutics?: Corcept Therapeutics' top insider investors include:
Joseph K Belanoff (CEO)
Joseph K Belanoff (Insider)
Joseph Cook, Jr (Director)
G Leonard Baker Jr (Director)
David L Mahoney (Director)
James N Wilson (Director)
G Leonard Baker, Jr (Director)
Patrick G Enright (Director)
Gary Charles Robb (CFO)
Gary Charles Robb (Insider)
Learn More about top insider investors at Corcept Therapeutics.
Who are the major institutional investors of Corcept Therapeutics?: Corcept Therapeutics' top institutional shareholders include:
Boston Trust Walden Corp — 0.22%
Bridge City Capital LLC — 0.06%
Nisa Investment Advisors LLC — 0.03%
State of Alaska Department of Revenue — 0.02%
Black Diamond Financial LLC — 0.02%
Yousif Capital Management LLC — 0.02%
Learn More about top institutional investors of Corcept Therapeutics stock.
Which institutional investors are selling Corcept Therapeutics stock?: During the last quarter, CORT stock was sold by these institutional investors:
Boston Trust Walden Corp
Curated Wealth Partners LLC
State of Alaska Department of Revenue
BOKF NA
VIRGINIA RETIREMENT SYSTEMS ET Al
First Citizens Bank & Trust Co.
Simplify Asset Management Inc.
Oppenheimer & Co. Inc.
During the previous year, company insiders that have sold Corcept Therapeutics company stock include:
Joseph K Belanoff (CEO)
David L Mahoney (Director)
James N Wilson (Director)
Kimberly Park (Director)
Atabak Mokari (CFO)
Joseph Douglas Lyon (Insider)
Sean Maduck (Insider)
William Guyer (Insider)
Roberto Wandenkolk Vieira (Insider)
Learn More investors selling Corcept Therapeutics stock.
Which institutional investors are buying Corcept Therapeutics stock?: In the previous quarter, CORT stock was bought by institutional investors including:
Nisa Investment Advisors LLC
Vilga Financial Planning LLC
Summit Global Investments
Bridge City Capital LLC
Range Financial Group LLC
Profund Advisors LLC
Vise Technologies Inc.
Englebert Financial Advisers LLC